Showing 61 - 80 results of 74,902 for search '(((( 5 a decrease ) OR ( 50 ((teer decrease) OR (mean decrease)) ))) OR ( 12 we decrease ))', query time: 0.40s Refine Results
  1. 61

    Decreased respiratory performance of children and adolescents with myelomeningocele who use a wheelchair – preliminary data by E.J. Martins (7141313)

    Published 2019
    “…MMC (n=10) and healthy (n=25) participants of both genders with a mean age of 12.45 years (SD=2.1) were assessed for weight, height, respiratory performance, and isometric peak for shoulder flexors, extensors, abductors, and adductors, using an isokinetic dynamometer. …”
  2. 62
  3. 63
  4. 64

    Table1_CLEC16A variants conferred a decreased risk to allergic rhinitis in the Chinese population.DOCX by Yongliang Niu (14245295)

    Published 2022
    “…</p><p>Conclusion:CLEC16A variants conferred a decreased risk to AR in the Chinese population.…”
  5. 65

    Table1_CLEC16A variants conferred a decreased risk to allergic rhinitis in the Chinese population.DOCX by Yongliang Niu (14245295)

    Published 2022
    “…</p><p>Conclusion:CLEC16A variants conferred a decreased risk to AR in the Chinese population.…”
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71

    Image_5_Decreased phase information transfer from the mPFC to the BLA: During exploratory behavior in CUMS rats.TIF by Qingying Cao (11842292)

    Published 2023
    “…</p>Results<p>Rats subjected to CUMS showed a decrease in exploratory behavior. The WPLI within the mPFC and the BLA showed strikingly higher phase synchrony at theta frequencies (4–12 Hz) than other frequency bands during exploratory behavior in both the control and CUMS groups. …”
  12. 72
  13. 73
  14. 74

    Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80